Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of participating physicians

From: Effectiveness of educational outreach visits compared with usual guideline dissemination to improve family physician prescribing—an 18-month open cluster-randomized trial

  Intervention Control
Physicians per cluster—mean (standard deviation) 6.3 (1.4) 6.3 (1.4)
Unit type—n units (n physicians)
 Family health unit 17 (107) 18 (114)
 Personalized care unit 2 (13) 1 (5)
Female, % 70.8 79.0
Age—years, median (P25P75) 52 (41–59) 47 (38–59)
Years in practice—median (P25P75) 13 (6.5–28) 11 (4–28)
Residency tutor, % 55.8 52.9
Patient list size—median (P25P75) 1874 (1812–1923) 1813 (1746–1872)
Prescription—mean (standard deviation)
 Omeprazole, % 47.13 (13.50) 48.30 (13.70)
 COX-2 inhibitors, % 13.20 (9.69) 14.67 (12.88)
 Clopidogrel, DDD/1000 patients 0.0986 (0.0502) 0.1053 (0.0491)
NHS expenditure with NSAIDs, acid secretion modifiers, and clopidogrel/month/1000—€, mean (standard deviation) 189.60 (73.41) 192.72 (85.67)
  1. P25, first quartile, P75 third quartile, COX-2 cycloxigenase-2, DDD defined daily dose, NHS National Health Service, NSAIDs non-steroidal anti-inflammatory drugs